KLRC1 and neoplasm: Despite activating receptors on the target enhance NK cell-mediated tumor lysis, expression of ligands on tumors to inhibitory NK receptors, such as NKG2A, TIGIT and LAG3, can induce NK cell exhaustion and suppress their anti-tumor function.